Pharmaceutical

Evaxion Biotech to develop new vaccines for cancer

Evaxion Biotech has announced plans to develop customised cancer vaccines by targeting a category of AI-discovered tumour antigens.

Jan 25, 2024 - 18:00
Evaxion Biotech to develop new vaccines for cancer
Evaxion Biotech has announced plans to develop customised cancer vaccines by targeting a category of AI-discovered tumour antigens.
Read the original article

Tags:

Previous Article

Harnessing the untapped potential of medicines access 

Next Article

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BMS and 2seventy bio’s Abecma gains approval for multiple myeloma

BMS and 2seventy bio’s Abecma gains approval for multip...

Apr 9, 2024

An MRI helmet out of ‘Back to the Future’ wins STAT Summit research pick

An MRI helmet out of ‘Back to the Future’ wins STAT Sum...

May 3, 2023

A comprehensive guide to supply chain management for specialty drugs

A comprehensive guide to supply chain management for sp...

Aug 25, 2024